Article: After the panic, clarifying the results of a cholesterol trial

Tara Parker-Pope The New York Times Media Group
International Herald Tribune
01-24-2008
After the panic, clarifying the results of a cholesterol trial
Byline: Tara Parker-Pope The New York Times Media Group
Edition: 1
Section: FEATURES

The cholesterol drug Vytorin combines Zocor, a cholesterol- lowering statin, with Zetia, a drug that limits cholesterol's absorption into the body, and the hope was that the combination would make it more effective than either drug standing alone. But last week Vytorin's makers, Merck and Schering-Plough, announced that in a small study it had performed no better than Zocor alone in slowing the growth of arterial plaque, which can lead to heart attacks. There's ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!